Evidence map›Paper›PMID 42871103›Full record

ArticleFrontiers in medicine2026

Case Report: Three rare cases of pseudomyogenic hemangioendothelioma with atypical skeletal involvement.

Meizheng Dang, Buyi Zhang, Wen Xu, Pintong Huang

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meizheng Dang *Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Buyi Zhang *Department of Pathology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Wen XuDepartment of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Pintong HuangDepartment of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pseudomyogenic hemangioendothelioma (PHE) is a rare vascular neoplasm of intermediate malignant potential that predominantly affects young adult men and most frequently arises in the lower extremities. Involvement of unusual skeletal sites is uncommon, and the nonspecific imaging features of PHE may contribute to diagnostic uncertainty. Case report: We report three cases of PHE involving unusual osseous locations, including the thoracic spine, femur, and humerus, with one case showing concomitant soft tissue involvement of the upper arm. Multimodal imaging, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET/CT), demonstrated osteolytic bone destruction, soft tissue extension, heterogeneous enhancement, and increased metabolic activity. All patients underwent individualized surgical management according to tumor location and disease extent. The final diagnosis was established by histopathological and immunohistochemical (IHC) evaluation, particularly FOSB positivity and endothelial marker expression. Conclusion: PHE should be considered in the differential diagnosis of atypical bone and soft tissue lesions, even when they occur at uncommon anatomic sites or in patients outside the typical demographic profile. Comprehensive imaging assessment, histopathological confirmation, individualized treatment, and long-term follow-up are essential for accurate diagnosis and optimal clinical management.

Indexed as

case reportcomputed tomographyhistopathological examinationimmunohistochemicalmagnetic resonance imagingpositron emission tomography/computed tomographypseudomyogenic hemangioendothelioma

Identifiers

PMID42871103
PMCPMC13658082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.